Need Assistance?

US & Canada:
+
UK: +

FAQs

Resources

Our Highlights

GMP Grade Efficient workshop for GMP production.
Optimal Prices Buying products on this site guarantees the best price!
Commercial Batches Independent GMP manufacturing suites that handle commercial batches
Prompt Delivery Warehouses in multiple cities to ensure timely delivery
Flexible Quantity Quantities available from milligrams to ton

Application Area

N-α-Carbobenzoxy-β-(4-pyridyl)-L-alanine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category

CBZ-Amino Acids

Catalog number

BAT-006931

CAS number

37535-53-8

Molecular Formula

C16H16N2O4

Molecular Weight

300.32

N-α-Carbobenzoxy-β-(4-pyridyl)-L-alanine

Synonyms

Z-Ala(4-Pyri)-OH; Z-Ala(4-Pyridyl)-OH

Purity

95%

Storage

Store at 2-8 °C

N-α-Carbobenzoxy-β-(4-pyridyl)-L-alanine, a synthetic derivative of amino acid, finds diverse applications in the realms of biochemistry and pharmaceuticals. Here are the key applications presented with a high degree of perplexity and burstiness:

Peptide Synthesis: Serving as a crucial element in solid-phase peptide synthesis, N-α-Carbobenzoxy-β-(4-pyridyl)-L-alanine acts as a protected amino acid essential for the intricate assembly of peptide chains. The carbobenzoxy (Z) group shields the amino function during coupling reactions facilitating the tailored construction of peptides for both research purposes and therapeutic endeavors. This method is indispensable for the precise synthesis of peptides endowed with specific characteristics pushing the boundaries of peptide science.

Enzyme Inhibition Studies: In the intricate realm of enzyme research, N-α-Carbobenzoxy-β-(4-pyridyl)-L-alanine emerges as a substrate analogue utilized to delve into enzyme activity and inhibition mechanisms. Scientists harness this compound to probe enzyme active sites unravel their specificity and decipher catalytic processes. The invaluable insights derived from these studies play a pivotal role in the design of potent enzyme inhibitors with potential applications as cutting-edge pharmaceutical agents steering the course of enzymology.

Protein Engineering: Within the expansive landscape of protein manipulation, researchers seamlessly integrate N-α-Carbobenzoxy-β-(4-pyridyl)-L-alanine into proteins to unravel intricate structure-function relationships. Through the strategic substitution of natural amino acids with this derivative, scientists can assess changes in protein stability folding dynamics and functional attributes. This approach aids in the crafting of proteins with enhanced or novel functionalities catering to a myriad of needs in industrial and therapeutic settings pushing the boundaries of protein engineering.

Bioconjugation: The unique structural attributes of N-α-Carbobenzoxy-β-(4-pyridyl)-L-alanine render it an ideal candidate for cutting-edge bioconjugation techniques. This compound can be seamlessly conjugated with a diverse array of biomolecules to fabricate targeted probes or therapeutic agents offering unparalleled flexibility in the realm of drug delivery systems and diagnostic tool development. Its significance lies in the ability to create specialized bioconjugates tailored for a wide spectrum of applications in the ever-evolving biomedical field revolutionizing the landscape of bioconjugation strategies.

1. Pyridyl-alanine as a Hydrophilic, Aromatic Element in Peptide Structural Optimization

Piotr A Mroz, Diego Perez-Tilve, Fa Liu, Vasily Gelfanov, Richard D DiMarchi, John P Mayer J Med Chem. 2016 Sep 8;59(17):8061-7. doi: 10.1021/acs.jmedchem.6b00840. Epub 2016 Aug 25.

Glucagon (Gcg) 1 serves a seminal physiological role in buffering against hypoglycemia, but its poor biophysical properties severely complicate its medicinal use. We report a series of novel glucagon analogues of enhanced aqueous solubility and stability at neutral pH, anchored by Gcg[Aib16]. Incorporation of 3- and 4-pyridyl-alanine (3-Pal and 4-Pal) enhanced aqueous solubility of glucagon while maintaining biological properties. Relative to native hormone, analogue 9 (Gcg[3-Pal6,10,13, Aib16]) demonstrated superior biophysical character, better suitability for medicinal purposes, and comparable pharmacology against insulin-induced hypoglycemia in rats and pigs. Our data indicate that Pal is a versatile surrogate to natural aromatic amino acids and can be employed as an alternative or supplement with isoelectric adjustment to refine the biophysical character of peptide drug candidates.

2. The behavior of substrate analogues and secondary deuterium isotope effects in the phenylalanine ammonia-lyase reaction

A Gloge, B Langer, L Poppe, J Rétey Arch Biochem Biophys. 1998 Nov 1;359(1):1-7. doi: 10.1006/abbi.1998.0860.

Metacresol and glycine can be thought as a dissection of metatyrosine, which is an excellent substrate of phenylalanine ammonia-lyase (PAL) (B. Schuster and J. Rétey, PNAS 92, 8433, 1995). Whereas metacresol was a very weak inhibitor and glycine was inert, simultaneous addition of both compounds led to synergistic inhibition of PAL. [2H5]Phenylalanine as a substrate showed a kinetic deuterium isotope effect of 9% (kH/k2H = 1.09 +/- 0.01) while its Km value was identical to that of the unlabeled substrate. The following substrate analogues were synthesized and assayed with PAL: cyclooctatetraenyl (COT)-d,l)-alanine as well as 2-pyridyl-, 3-pyridyl-, and 4-pyridyl-(l)-alanines. While COT-(d,l)-alanine turned out to be a rather reluctant substrate, all three isomers of pyridyl-(l)-alanines were converted with a comparable or even higher Vmax than l-phenylalanine into the corresponding pyridyl acrylic acids. Their Km values were, however, an order of magnitude higher than that of the natural substrate. These results are discussed in terms of the novel mechanism which implies an electrophilic attack of the prosthetic dehydroalanine at the aromatic ring. The heats of formation of the putative sigma complexes of the electrophilic substitution at the pyridine ring have been calculated using semiempirical force-field methods. The results show the feasibility of the proposed mechanism also with the substrate analogues.

3. Biocompatible Macrocyclization between Cysteine and 2-Cyanopyridine Generates Stable Peptide Inhibitors

Christoph Nitsche, Hideki Onagi, Jun-Ping Quek, Gottfried Otting, Dahai Luo, Thomas Huber Org Lett. 2019 Jun 21;21(12):4709-4712. doi: 10.1021/acs.orglett.9b01545. Epub 2019 Jun 12.

Peptides featuring an N-terminal cysteine residue and the unnatural amino acid 3-(2-cyano-4-pyridyl)alanine (Cpa) cyclize spontaneously in aqueous solution at neutral pH. Cpa is readily available and easily introduced into peptides using standard solid-phase peptide synthesis. The reaction is orthogonal to all proteinogenic amino acids, including cysteine residues that are not at the N-terminus. A substrate peptide of the Zika virus NS2B-NS3 protease cyclized in this way produced an inhibitor of high affinity and proteolytic stability.